Curaleaf Holdings (CURLF) EPS (Basic) (QoQ) (2019 - 2026)
Curaleaf Holdings (CURLF) EPS (Basic) (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 131.19% |
| Mar 31, 2026 | 98.16% |
| Dec 31, 2025 | -634.95% |
| Sep 30, 2025 | 29.53% |
| Jun 30, 2025 | 71.01% |
| Mar 31, 2025 | 10.35% |
| Dec 31, 2024 | -797.09% |
| Sep 30, 2024 | 227.02% |
| Jun 30, 2024 | -323.81% |
| Mar 31, 2024 | 100.01% |
| Dec 31, 2023 | -30,801.75% |
| Sep 30, 2023 | -225.14% |
| Jun 30, 2023 | 37.32% |
| Mar 31, 2023 | 85.56% |
| Dec 31, 2022 | -576.83% |
| Sep 30, 2022 | -182.90% |
| Jun 30, 2022 | -121.03% |
| Mar 31, 2022 | 501.97% |
| Dec 31, 2021 | -108.19% |
| Sep 30, 2021 | -16.49% |